TKI258, a novel, multitargeted tyrosine kinase inhibitor for the treatment of breast cancer

被引：0
|
作者：
Liu, H. [1 ]
Schulz, C. O. [1 ]
Regierer, A. C. [1 ]
Dieing, A. [1 ]
Possinger, K. [1 ]
Eucker, J. [1 ]
机构：
[1] Charite Campus Mitte, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14625
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib
    Zhao, Shu
    Wang, Peng
    Yin, Fan
    Wu, Junjie
    Wang, Yuying
    Li, Peng
    Zhang, Yong
    Yang, Jing
    Guo, Xueguang
    Zhang, Dong
    Song, Peng
    TUMORI JOURNAL, 2023, 109 (02): : 186 - 196
  • [42] Sunitinib malate -: Oncolytic drug multitargeted tyrosine kinase inhibitor
    McIntyre, JA
    Castañer, J
    DRUGS OF THE FUTURE, 2005, 30 (08) : 785 - 792
  • [43] Impact of Tyrosine Kinase Inhibitor (TKI) Dose on Outcomes of Patients with Lung Cancer
    Miao, E.
    Eng, S.
    Lee, C.
    Seetharamu, N.
    Sullivan, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S813 - S813
  • [44] Antiangiogenic therapy of cancer by multitargeted tyrosine kinase inhibitors
    Agata, Naoki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 40P - 40P
  • [45] Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
    Kumar, Suresh
    Agrawal, Ritesh
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2014, 9 (03) : 382 - 393
  • [46] The anticancer kinase inhibitor dovitinib (TKI258/CHIR258) may have multiple modes of action because it also binds DNA and inhibits topoisomerase I and topoisomerase IIα
    Wu, Xing
    Yalowich, Jack C.
    Hasinoff, Brian
    CANCER RESEARCH, 2011, 71
  • [47] Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond
    Ou, Sai-Hong Ignatius
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 471 - 485
  • [48] Curcumin as tyrosine kinase inhibitor in cancer treatment
    Golonko, A.
    Lewandowska, H.
    Swislocka, R.
    Jasinska, U. T.
    Priebe, W.
    Lewandowski, W.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 181
  • [49] Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
    Lin, Wen-Hsing
    Wu, Su-Ying
    Yeh, Teng-Kuang
    Chen, Chiung-Tong
    Song, Jen-Shin
    Shiao, Hui-Yi
    Kuo, Ching-Chuan
    Hsu, Tsu
    Lu, Cheng-Tai
    Wang, Pei-Chen
    Wu, Tsung-Sheng
    Peng, Yi-Hui
    Lin, Hui-You
    Chen, Ching-Ping
    Weng, Ya-Ling
    Kung, Fang-Chun
    Wu, Mine-Hsine
    Su, Yu-Chieh
    Huang, Kuo-Wei
    Chou, Ling-Hui
    Hsueh, Ching-Cheng
    Yen, Kuei-Jung
    Kuo, Po-Chu
    Huang, Chen-Lung
    Chen, Li-Tzong
    Shih, Chuan
    Tsai, Hui-Jen
    Jiaang, Weir-Torn
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (24) : 11135 - 11150
  • [50] Gray Hair Associated with the Multitargeted Receptor Tyrosine Kinase Inhibitor Pazopanib
    Yun, Hwan-Jung
    Seo, Young Joon
    Lee, Hyo Jin
    ANNALS OF DERMATOLOGY, 2015, 27 (06) : 791 - 792
12345